| Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia AE Tron, MA Belmonte, A Adam, BM Aquila, LH Boise, E Chiarparin, ... Nature communications 9 (1), 5341, 2018 | 435 | 2018 |
| Crystal structure of DNA recombination protein RuvA and a model for its binding to the Holliday junction JB Rafferty, SE Sedelnikova, D Hargreaves, PJ Artymiuk, PJ Baker, ... Science 274 (5286), 415-421, 1996 | 214 | 1996 |
| Crystal structure of E.coli RuvA with bound DNA Holliday junction at 6 Å resolution D Hargreaves, DW Rice, SE Sedelnikova, PJ Artymiuk, RG Lloyd, ... Nature structural biology 5 (6), 441-446, 1998 | 170 | 1998 |
| Development of a novel B-cell lymphoma 6 (BCL6) PROTAC to provide insight into small molecule targeting of BCL6 W McCoull, T Cheung, E Anderson, P Barton, J Burgess, K Byth, Q Cao, ... ACS Chemical Biology 13 (11), 3131-3141, 2018 | 130 | 2018 |
| Structure of IL-17A in complex with a potent, fully human neutralizing antibody S Gerhardt, WM Abbott, D Hargreaves, RA Pauptit, RA Davies, ... Journal of molecular biology 394 (5), 905-921, 2009 | 101 | 2009 |
| Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains S Gerhardt, G Hassall, P Hawtin, E McCall, L Flavell, C Minshull, ... Journal of molecular biology 373 (4), 891-902, 2007 | 101 | 2007 |
| Structural and functional analysis of the kid toxin protein from E. coli plasmid R1 D Hargreaves, S Santos-Sierra, R Giraldo, R Sabariegos-Jareño, ... Structure 10 (10), 1425-1433, 2002 | 97 | 2002 |
| Computational design of epitope-specific functional antibodies G Nimrod, S Fischman, M Austin, A Herman, F Keyes, O Leiderman, ... Cell reports 25 (8), 2121-2131. e5, 2018 | 71 | 2018 |
| Using isoelectric point to determine the pH for initial protein crystallization trials J Kirkwood, D Hargreaves, SOKJ Wilson Bioinformatics 2015, 1-8, doi: 10.1093/bioinformatics/btv011, 2015 | 71 | 2015 |
| Structure based design of non-natural peptidic macrocyclic Mcl-1 inhibitors JW Johannes, S Bates, C Beigie, MA Belmonte, J Breen, S Cao, ... ACS medicinal chemistry letters 8 (2), 239-244, 2017 | 70 | 2017 |
| Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors W McCoull, RD Abrams, E Anderson, K Blades, P Barton, M Box, ... Journal of Medicinal Chemistry 60 (10), 4386-4402, 2017 | 67 | 2017 |
| Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3S)-1-[5 … JS Scott, SS Bowker, J Deschoolmeester, S Gerhardt, D Hargreaves, ... Journal of medicinal chemistry 55 (12), 5951-5964, 2012 | 57 | 2012 |
| Shifts PJ Baker, D Hargreaves, S Bailey, JB Rafferty, PJ Artymiuk, DW Rice Routledge encyclopedia of translation studies, 289-293, 2009 | 55 | 2009 |
| Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: The discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl … JS Scott, J deSchoolmeester, E Kilgour, RM Mayers, MJ Packer, ... Journal of medicinal chemistry 55 (22), 10136-10147, 2012 | 49 | 2012 |
| Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors CS Colley, B Popovic, S Sridharan, JE Debreczeni, D Hargeaves, M Fung, ... MAbs 10 (1), 104-117, 2018 | 33 | 2018 |
| Abstract DDT01-02: AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancers AW Hird, JP Secrist, A Adam, MA Belmonte, E Gangl, F Gibbons, ... Cancer Research 77 (13_Supplement), DDT01-02-DDT01-02, 2017 | 30 | 2017 |
| Analysis of crystallization data in the Protein Data Bank J Kirkwood, D Hargreaves, S O'Keefe, J Wilson Acta Crystallographica Section F: Structural Biology Communications 71 (10 …, 2015 | 28 | 2015 |
| Structural similarities between Escherichia coli RuvA protein and other DNA-binding proteins and a mutational analysis of its binding to the Holliday junction JB Rafferty, SM Ingleston, D Hargreaves, PJ Artymiuk, GJ Sharples, ... Journal of molecular biology 278 (1), 105-116, 1998 | 28 | 1998 |
| Selective non zinc binding inhibitors of MMP13 C De Savi, AD Morley, A Ting, I Nash, K Karabelas, CM Wood, M James, ... Bioorganic & medicinal chemistry letters 21 (14), 4215-4219, 2011 | 26 | 2011 |
| Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope DC Lowe, S Gerhardt, A Ward, D Hargreaves, M Anderson, F Ferraro, ... Journal of molecular biology 406 (1), 160-175, 2011 | 23 | 2011 |
Stefan GerhardtUniversity of Freiburg
Stefan GerhardtUniversity of Freiburg